Aarti Pharmalabs Limited has responded to a clarification request from the National Stock Exchange of India Limited (NSE) concerning a significant increase in the trading volume of its securities. In its reply dated January 12, 2026, the company stated that it has been promptly disseminating all required information and events as per SEBI regulations.

The company further clarified that, apart from the information already disclosed, there is no pending announcement that could be influencing the price or volume behavior of its scrip. Aarti Pharmalabs Limited concluded that the observed increase in trading volume is purely market-driven.

This response was in reference to an email from NSE's Surveillance department dated January 09, 2026, which sought clarification on the unusual trading activity.